Q3 LONG ANSWER 10M ★ High-yield

Describe Non-depolarising Muscle Relaxants in detail.

General Surgery · Final Professional

Overview

Non-depolarising muscle relaxants are competitive antagonists at the nicotinic receptor, producing paralysis without fasciculations and with a slower onset and longer duration than suxamethonium. They are used for maintenance of relaxation during surgery and are reversible by anticholinesterases (neostigmine) (or, for the aminosteroids, by sugammadex). They are classified as aminosteroids (vecuronium, rocuronium, pancuronium) or benzylisoquinoliniums (atracurium, cisatracurium, mivacurium).

Agent	Onset/duration	Elimination / note
Rocuronium	Fast / intermediate	Hepatic; RSI alternative to sux; reversed by sugammadex
Vecuronium	Intermediate	Hepatic/renal; cardiostable
Atracurium	Intermediate	Hofmann elimination (organ-independent) — renal/hepatic failure
Cisatracurium	Intermediate	Hofmann; little histamine release
Pancuronium	Slow / long	Renal; vagolytic (tachycardia)

Choosing an Agent

The choice depends on the desired onset, duration and elimination and on patient factors.
Rocuronium has a rapid onset and is the main non-depolarising alternative for rapid sequence induction (and is reversible by sugammadex).
Atracurium and cisatracurium undergo Hofmann elimination (spontaneous, organ-independent breakdown), making them ideal in renal or hepatic failure.
Pancuronium is long-acting and vagolytic (causes tachycardia).

Adverse Effects

Class effects are relatively few. Some (e.g. atracurium, and the older tubocurarine) cause histamine release (hypotension, flushing, bronchospasm); pancuronium causes tachycardia (vagolytic); accumulation occurs if elimination is impaired (except the Hofmann agents). As with all relaxants, residual block at the end of surgery risks hypoventilation and airway compromise — hence monitoring and reversal.

CLINICAL PEARL

Two high-yield choices: use rocuronium when you need a rapid onset without suxamethonium (and rapid reversal with sugammadex), and use atracurium/cisatracurium in renal or hepatic failure because Hofmann elimination is independent of these organs.

DANGER / REMEMBER

Residual neuromuscular block at the end of anaesthesia is dangerous — it causes weakness, hypoventilation, airway obstruction and aspiration. Always monitor the block (train-of-four) and ensure adequate reversal/recovery before extubation.

Duration & the Problem of Accumulation

Non-depolarising agents are commonly grouped by duration into short, intermediate and long-acting, and the choice is guided by the length of surgery and the need to avoid residual block at the end. The long-acting agents such as pancuronium provide prolonged relaxation from a single dose but accumulate and are difficult to reverse fully in time for extubation; the intermediate agents (rocuronium, vecuronium, atracurium, cisatracurium) are now favoured for most surgery because they are more easily titrated and reversed. Accumulation is a particular hazard where elimination is impaired — renal failure for the renally-excreted agents, hepatic failure for the hepatically-cleared ones — which is precisely why the organ-independent Hofmann elimination of atracurium and cisatracurium is so valued in these patients.

CLINICAL PEARL

Anchor two choices in memory: rocuronium for a rapid onset without suxamethonium (and rapid sugammadex reversal), and atracurium or cisatracurium in renal or hepatic failure because their Hofmann elimination is independent of those organs — while remembering that residual block from any of them must be excluded before extubation.

DANGER / REMEMBER

Whichever non-depolarising agent is used, the shared danger is residual block at the end of surgery, which impairs the airway and breathing muscles; it is prevented by monitoring the train-of-four and confirming a ratio above 0.9 (or giving sugammadex for an aminosteroid) before the tube is removed.

Fade and post-tetanic facilitation characterise non-depolarising block.

KEY POINT

Key points TO remember

Non-depolarising = competitive antagonists; no fasciculations, slower/longer; reversible by neostigmine (sugammadex for aminosteroids).
Aminosteroids (rocuronium, vecuronium, pancuronium) & benzylisoquinoliniums (atracurium, cisatracurium, mivacurium).
Rocuronium: rapid onset → RSI alternative, sugammadex-reversible.
Atracurium/cisatracurium: Hofmann elimination → ideal in renal/hepatic failure.
Watch for histamine release (atracurium), tachycardia (pancuronium), & residual block — monitor & reverse.

EXAM TIP

Sources: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.

All questions in Muscle Relaxants

Every General Surgery chapter →